Literature DB >> 2171802

Biphasic effects of doxorubicin on the calcium release channel from sarcoplasmic reticulum of cardiac muscle.

K Ondrias1, L Borgatta, D H Kim, B E Ehrlich.   

Abstract

To define the mechanism of doxorubicin cardiotoxicity, the effects of doxorubicin and caffeine were examined on calcium release channels from cardiac sarcoplasmic reticulum. We found that calcium release from cardiac sarcoplasmic reticulum vesicles was induced by both compounds. When sarcoplasmic reticulum vesicles were incorporated into planar lipid bilayers, calcium-permeable channels were observed. Addition of caffeine (2.5-10 mM) increased channel open probability from less than 0.1% to 40%, and this effect persisted for a mean of 44 minutes. In contrast, doxorubicin (2.5-10 microM) had a biphasic effect; initially, doxorubicin activated the channel, whereas after a mean of 8 minutes, the channel became irreversibly inhibited. Although the degree of channel activation by doxorubicin was concentration dependent, the time needed to inactivate the channel was concentration independent. Pretreatment with dithiothreitol (0.2 mM) prevented doxorubicin-induced channel inactivation, and channel activity persisted for an average of 58 minutes. Dithiothreitol alone did not alter channel open probability. Our results support the hypotheses that 1) the integrity of sulfhydryl groups is important for some aspects of calcium release channel function and 2) activation and inactivation of the channel are separable processes. The biphasic effect of doxorubicin on channel function may also correspond to the clinically observed adverse effects of doxorubicin, a widely used chemotherapeutic agent that, after prolonged usage, causes a dilated cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171802     DOI: 10.1161/01.res.67.5.1167

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  13 in total

Review 1.  Ion conduction and discrimination in the sarcoplasmic reticulum ryanodine receptor/calcium-release channel.

Authors:  A J Williams
Journal:  J Muscle Res Cell Motil       Date:  1992-02       Impact factor: 2.698

2.  Regional differences in calcium-release channels from heart.

Authors:  L Borgatta; J Watras; A M Katz; B E Ehrlich
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

3.  Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart.

Authors:  R Zucchi; G Yu; S Ghelardoni; F Ronca; S Ronca-Testoni
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Oxidation of RyR2 Has a Biphasic Effect on the Threshold for Store Overload-Induced Calcium Release.

Authors:  Helen M M Waddell; Joe Z Zhang; Katie J Hoeksema; Julia J McLachlan; Janet C McLay; Peter P Jones
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

5.  Doxorubicin causes lesions in the electron transport system of skeletal muscle mitochondria that are associated with a loss of contractile function.

Authors:  Michael D Tarpey; Adam J Amorese; Nicholas P Balestrieri; Kelsey H Fisher-Wellman; Espen E Spangenburg
Journal:  J Biol Chem       Date:  2019-11-05       Impact factor: 5.157

6.  Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

Authors:  D A Dodd; J B Atkinson; R D Olson; S Buck; B J Cusack; S Fleischer; R J Boucek
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Procaine effects on single sarcoplasmic reticulum Ca2+ release channels.

Authors:  A Zahradníková; P Palade
Journal:  Biophys J       Date:  1993-04       Impact factor: 4.033

8.  Doxorubicin-induced vasomotion and [Ca(2+)](i) elevation in vascular smooth muscle cells from C57BL/6 mice.

Authors:  Bing Shen; Chun-ling Ye; Kai-he Ye; Lan Zhuang; Jia-hua Jiang
Journal:  Acta Pharmacol Sin       Date:  2009-10-12       Impact factor: 6.150

9.  Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A.

Authors:  Amy D Hanna; Alex Lam; Steffi Tham; Angela F Dulhunty; Nicole A Beard
Journal:  Mol Pharmacol       Date:  2014-08-08       Impact factor: 4.436

10.  Modification of cardiac Ca2+ release channel gating by DIDS.

Authors:  A Zahradníková; I Zahradník
Journal:  Pflugers Arch       Date:  1993-12       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.